Monoclonal Antibodies: A Potential Treatment for #COVID19
Monoclonal Antibodies: A Potential Treatment for #COVID19
Curious about how antibodies work to protect our health? In August of 2020, the NIH launched clinical trials to investigate the use of monoclonal antibodies as a potential treatment for COVID-19.Learn more about how monoclonal antibodies and how they are used to treat disease - tune in now!
For more information about NIH's COVID-19 efforts, visit: https://covid19.nih.gov/ or follow @nihgov on Instagram.
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.